Proheptazine
Proheptazine is a synthetic opioid analgesic that is structurally related to methadone. It was first synthesized in the mid-20th century and has been used in the management of moderate to severe pain. Proheptazine is known for its potent analgesic properties and is typically administered orally.
Pharmacology[edit]
Proheptazine works by binding to the mu-opioid receptors in the central nervous system, which leads to the inhibition of pain signals. Like other opioids, it can produce effects such as euphoria, sedation, and respiratory depression. The drug's efficacy and side effect profile are similar to those of other opioids, making it a valuable option in pain management.
Medical Uses[edit]
Proheptazine is primarily used for the relief of moderate to severe pain. It is often prescribed when other pain management strategies are insufficient. Due to its potential for addiction and abuse, its use is typically monitored closely by healthcare providers.
Side Effects[edit]
Common side effects of proheptazine include:
Serious side effects can include:
- Respiratory depression
- Hypotension
- Bradycardia
- Dependence and withdrawal symptoms
Contraindications[edit]
Proheptazine should not be used in individuals with a history of opioid addiction or in those with severe respiratory disorders. It is also contraindicated in patients with hypersensitivity to the drug or any of its components.
Legal Status[edit]
The legal status of proheptazine varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and dependence.